The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study

A. Modi, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellstrom, J. P. Weaver, J. P. van den Bergh, P. Keown, S. Sajjan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalOsteoporosis International
Volume29
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Adherence
  • Gastrointestinal events
  • Medication
  • Osteoporosis
  • Persistence
  • POSTMENOPAUSAL WOMEN
  • BISPHOSPHONATE THERAPY
  • CLINICAL-PRACTICE
  • FRACTURE RISK
  • ORAL BISPHOSPHONATES
  • MEDICATION ADHERENCE
  • ALENDRONATE THERAPY
  • DATABASE ANALYSIS
  • UNITED-STATES
  • DETERMINANTS

Cite this